期刊文献+

祛浊化痰中药对AS家兔血管成形术后炎性因子表达的影响 被引量:4

Turbid Phlegm Removing Rabbits by High Fat Diet-related Factors After Angioplasty of Inflammatory
下载PDF
导出
摘要 目的:观察祛浊化痰中药(通脉颗粒)对高脂饮食兔血管成形术后炎性因子hs-CRP、ICAM-1、NF-KB的影响。方法:选择新西兰大耳白兔50只随机分为空白组、模型组、中药组、西药组、中西药组各10只,通过喂养高脂饲料建立家兔AS模型,8周后造血管内皮球囊拉伤模型,测定hs-CRP含量及各组ICAM-1、NF-KBmRNA表达。结果:通脉颗粒可显著下调高脂饮食兔血管成形术后病灶中hs-CRP含量,且能明显降低家兔血清ICAM-1、NF-KBmRNA表达水平(P<0.05)。结论:通脉颗粒能减少AS斑块内的炎性因子表达,并可抑制血管内皮拉伤后相关炎性因子的表达,以减少AS的形成及防止术后再狭窄。其作用机制可能与调脂、抗炎的作用有关。 Objective: To observe the cured turbid phlegm medicine (Tongmai particles) on the high fat diet rabbits after balloon angioplasty inflammation - associated factor hs - CRP, ICAM - 1, NF - kB effects. Methods: 50 New Zeal- and white rabbits were randomly divided into blank group, model group, group, western medicine group, in the western group 10, through the high fat diet rabbits AS model, to the high fat diet for 8 weeks create vascular endothelial balloon injury model, determination of hs -CRP levels and the group of ICAM -1, NF -KBmRNA expression. Results: Tongmai particles can significantly lower high - fat diet after angioplasty lesions in rabbits hs - CRP levels, and can significantly reduce the rabbit serum ICAM - 1, NF - KBmRNA expression level ( P 〈 O. 05). Conclusion: AS Tongmai particles can reduce the expression of inflammatory factors within the plaque, and inhibit vascular Neipi La injury related to the expression of inflammatory factors in order to reduce the formation of AS and prevent restenosis. The mechanism may be re- lated to lipid lowering, anti - inflammatory effects.
出处 《中华中医药学刊》 CAS 2011年第2期241-243,共3页 Chinese Archives of Traditional Chinese Medicine
关键词 祛浊化痰法 细胞黏附分子(ICAM-1) 高敏C反应蛋白(.hs-CRP) 核因子-KB(NF—KB) Qu turbid phlegm cell adhesion molecule ( ICAM - 1 ) high - sensitivity C - reactive protein ( hs - CRP) nuclear factor - KB ( NF - KB)
  • 相关文献

参考文献7

二级参考文献26

  • 1周小明,陆再英.丹参注射液对培养的动脉平滑肌细胞增殖的影响[J].中药药理与临床,1995,11(3):31-32. 被引量:19
  • 2孟振行,吴淑敏,孙仁俊,王德修.丹参防治动脉粥样硬化的机理[J].心肺血管病杂志,1993,12(2):121-123. 被引量:35
  • 3乔宦琏.大柴胡汤为主治疗急性胆系感染75例[J].上海中医药杂志,1994,28(12):20-21. 被引量:8
  • 4吴浩,袁伯俊.水蛭的药理作用和临床应用研究进展[J].药学实践杂志,1995,13(1):37-39. 被引量:7
  • 5刘西华 戴西湖.血府逐瘀汤在近代医学中的应用[J].福建中医药,1988,19:58-61.
  • 6陈可冀 史大卓.中医药防治冠状动脉手术后再狭窄研究取得显著进展[J].中国中医药信息杂志,1996,3(5):35-35.
  • 7秦腊梅.益气方对血液系统的影响[J].中药药理与临床,1998,4(3):25-25.
  • 8Prevention of cardiovascular events and death with Pravastatin in patients with coronary heart disease and a broad rang of initial cholesterol levels. The Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Group. N Engl J Med, 1998,339: 1349-1357.
  • 9Serruys PW, de Feyter P, Macaya C, et al. Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial.JAMA, 2002 ,287:3215-3222.
  • 10Ruygrok PN, de Jaegere PT, van Domburg RT, et al. Clinical outcome 10 years after attempted percutaneous transluminal coronary angioplasty in 856 patients. J Am Coll Cardiol, 1996,27: 1669-1677.

共引文献181

同被引文献36

引证文献4

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部